Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00890682 · ClinicalTrials.gov registry record · Phase 3
Study of Postoperative Analgesia in Bunionectomy
A Phase 3 study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 193
- Enrollment target
NCT00890682 is a Phase 3 study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 193 participants.
The verdict
NCT00890682, a Phase 3 study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 193 participants
- Enrollment target
Study Summary
After undergoing bunion surgery, patients are given a pain medicine injection that may last for up to several days or a placebo. Their pain and pain medicine use is then monitored.
Interventions
- DRUG Placebo
- DRUG SKY0402
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00890682
The ClinicalTrials.gov registry entry for NCT00890682 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00890682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00890682 about?
NCT00890682 is a clinical study titled "Study of Postoperative Analgesia in Bunionectomy". After undergoing bunion surgery, patients are given a pain medicine injection that may last for up to several days or a placebo. Their pain and pain medicine use is then monitored.
What is the current status of trial NCT00890682?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 193 participants. The study started on 2009-04. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00890682?
The interventions under investigation include: Placebo (DRUG), SKY0402 (DRUG).
Who is sponsoring clinical trial NCT00890682?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.